Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients.
Brain. 2020 May 1;143(5):1414-1430. doi: 10.1093/brain/awaa084.
Brain. 2020.
PMID: 32282893
Free article.
The presence and suppressive activity of myeloid-derived suppressor cells are potentiated after interferon-β treatment in a murine model of multiple sclerosis.
Melero-Jerez C, Suardíaz M, Lebrón-Galán R, Marín-Bañasco C, Oliver-Martos B, Machín-Díaz I, Fernández Ó, de Castro F, Clemente D.
Melero-Jerez C, et al. Among authors: machin diaz i.
Neurobiol Dis. 2019 Jul;127:13-31. doi: 10.1016/j.nbd.2019.02.014. Epub 2019 Feb 21.
Neurobiol Dis. 2019.
PMID: 30798007
Free article.
Item in Clipboard
The proportion of myeloid-derived suppressor cells in the spleen is related to the severity of the clinical course and tissue damage extent in a murine model of multiple sclerosis.
Melero-Jerez C, Alonso-Gómez A, Moñivas E, Lebrón-Galán R, Machín-Díaz I, de Castro F, Clemente D.
Melero-Jerez C, et al. Among authors: machin diaz i.
Neurobiol Dis. 2020 Jul;140:104869. doi: 10.1016/j.nbd.2020.104869. Epub 2020 Apr 9.
Neurobiol Dis. 2020.
PMID: 32278882
Free article.
Item in Clipboard
Functional Heterogeneity of Mouse and Human Brain OPCs: Relevance for Preclinical Studies in Multiple Sclerosis.
Bribián A, Medina-Rodríguez EM, Josa-Prado F, García-Álvarez I, Machín-Díaz I, Esteban PF, Murcia-Belmonte V, Vega-Zelaya L, Pastor J, Garrido L, de Castro F.
Bribián A, et al. Among authors: machin diaz i.
J Clin Med. 2020 Jun 2;9(6):1681. doi: 10.3390/jcm9061681.
J Clin Med. 2020.
PMID: 32498223
Free PMC article.
Item in Clipboard
Graphene oxide films as a novel tool for the modulation of myeloid-derived suppressor cell activity in the context of multiple sclerosis.
Camacho-Toledano C, Machín-Díaz I, Lebrón-Galán R, González-Mayorga A, Palomares FJ, Serrano MC, Clemente D.
Camacho-Toledano C, et al. Among authors: machin diaz i.
Nanoscale. 2024 Apr 18;16(15):7515-7531. doi: 10.1039/d3nr05351b.
Nanoscale. 2024.
PMID: 38498071
Item in Clipboard
Central and peripheral myeloid-derived suppressor cell-like cells are closely related to the clinical severity of multiple sclerosis.
Ortega MC, Lebrón-Galán R, Machín-Díaz I, Naughton M, Pérez-Molina I, García-Arocha J, Garcia-Dominguez JM, Goicoechea-Briceño H, Vila-Del Sol V, Quintanero-Casero V, García-Montero R, Galán V, Calahorra L, Camacho-Toledano C, Martínez-Ginés ML, Fitzgerald DC, Clemente D.
Ortega MC, et al. Among authors: machin diaz i.
Acta Neuropathol. 2023 Aug;146(2):263-282. doi: 10.1007/s00401-023-02593-x. Epub 2023 May 27.
Acta Neuropathol. 2023.
PMID: 37243699
Free PMC article.
Item in Clipboard
Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis.
Camacho-Toledano C, Machín-Díaz I, Calahorra L, Cabañas-Cotillas M, Otaegui D, Castillo-Triviño T, Villar LM, Costa-Frossard L, Comabella M, Midaglia L, García-Domínguez JM, García-Arocha J, Ortega MC, Clemente D.
Camacho-Toledano C, et al. Among authors: machin diaz i.
J Neuroinflammation. 2022 Nov 19;19(1):277. doi: 10.1186/s12974-022-02635-3.
J Neuroinflammation. 2022.
PMID: 36403026
Free PMC article.
Item in Clipboard
Cite
Cite